Literature DB >> 8650696

Change of the sex-dependent response to clofibrate in F344 rat liver during postnatal development.

T Yamoto1, Y Ohashi, T Furukawa, M Teranishi, S Manabe, T Makita.   

Abstract

Although it has been reported that male rats are more responsive than females to peroxisome proliferation induced by clofibrate, these sex differences have been confirmed in young adult rats. Using 4-, 8-, and 12-week-old F344 rats, postnatal change of the sex-dependent response to clofibrate was investigated. These animals were administered 200 mg/kg body wt./day clofibrate by gavage for 7 days. In 4-week-old rats clofibrate-dependent changes (hepatomegaly, induction of hepatic microsomal and peroxisomal enzymes, proliferation of smooth endoplasmic reticulum and peroxisomes of hepatocytes) were slight in both sexes. In 8- and 12-week-old rats clofibrate-induced changes of males were moderate, whereas those of females were slight. These results suggest that the responsiveness of immature rat to clofibrate is weak and in males the susceptibility is gradually strong during postnatal development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650696     DOI: 10.1016/0378-4274(96)03643-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio).

Authors:  Ananda B Venkatachalam; Santosh P Lall; Eileen M Denovan-Wright; Jonathan M Wright
Journal:  BMC Evol Biol       Date:  2012-07-09       Impact factor: 3.260

2.  Effect of a Large Dose of Di (2-ethylhexyl) phthalate (DEHP) on Hepatic Peroxisome in Cynomolgus Monkeys (Macaca Fascicularis).

Authors:  Shigeru Satake; Chika Nakamura; Yoshiyuki Minamide; Shinobu Kudo; Hiroshi Maeda; Yutaka Chihaya; Yasuhiro Kamimura; Hiroaki Miyajima; Jun Sasaki; Masanobu Goryo; Kosuke Okada
Journal:  J Toxicol Pathol       Date:  2010-06-30       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.